WHISTLER, British Columbia, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Whistler Medical Marijuana Corp. (“WMMC” or the “Company”), Canada’s original organic certified producer of medical cannabis, is pleased to announce they have been issued a Cultivation Licence from Health Canada that allows the Company to begin growing in Phase 1 of its new 62,000 sq. ft.  facility in Pemberton, British Columbia.

The newly completed, purpose built Pemberton facility significantly increases the Company’s existing footprint and production capacity. Phase 1 of the expansion lights up an additional 4 flowering rooms, and also includes a 1,000 sq. ft. laboratory that is currently undergoing certification for EU-GMP.

“We are very excited to obtain licensing for our second production facility. Phase 1 of Pemberton represents a milestone in the expansion and development of our organic certified production capabilities,” commented Christopher Pelz, CEO of WMMC. “Our team is focused on reproducing our existing proven techniques as we scale up to continue to meet the strong demand for quality, organic certified cannabis in Canada.”

WMMC maintains a quality-first approach in its cultivation, corporate governance, and operations, as well continues to build a sustainable and profitable business with outstanding customer service.

About Whistler Medical Marijuana Corp.

Whistler Medical Marijuana Corp. produces one of the most extensive cannabis strain and product selections in Canada. All their products are grown and produced by hand from their facilities in British Columbia.

In 2014, WMMC became the first producer to obtain organic status, and remain the only producer selling organic certified products in the country. They are governed by the simple philosophy of growing organic cannabis in soil without the use of chemicals which they do with integrity and a commitment to producing high quality products.

Contact:
Sophie Rivers
sophie@wmmc.ca